Fundz

Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer

PRIVATEMay 29, 2024

Position

Chief Legal Officer

Company

Alkeus Pharmaceuticals

Eric L. Trachtenberg
eric@alkeus.com
CambridgeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Description

Alkeus Pharmaceuticals, Inc. has announced the appointment of Eric L. Trachtenberg, J.D., M.B.A., as Chief Legal Officer

Quick answer

Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer (May 29, 2024). Alkeus Pharmaceuticals is based in Cambridge, Massachusetts, United States.

Who is the new Chief Legal Officer at Alkeus Pharmaceuticals?
Alkeus Pharmaceuticals named Eric L. Trachtenberg Chief Legal Officer, announced May 29, 2024.
What did Alkeus Pharmaceuticals announce on May 29, 2024?
Alkeus Pharmaceuticals, Inc. has announced the appointment of Eric L. Trachtenberg, J.D., M.B.A., as Chief Legal Officer
What does Alkeus Pharmaceuticals do?
Alkeus Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts.
Where is Alkeus Pharmaceuticals based?
Alkeus Pharmaceuticals is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Tarsier Pharma (May 28, 2024), Nurix Therapeutics (May 28, 2024), Crinetics Pharmaceuticals (May 30, 2024) and Contineum Therapeutics (June 3, 2024) also announced leadership changes within 45 days of Alkeus Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Alkeus Pharmaceuticals, and when

A new leader at Alkeus Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Alkeus Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alkeus Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alkeus Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alkeus Pharmaceuticals

Location

Cambridge, Massachusetts, United States

About

Alkeus Pharmaceuticals is a biopharmaceutical company headquartered in Cambridge, Massachusetts. The company is focused on developing therapies for serious diseases of the eye with high unmet need. Alkeus' lead candidate, gildeuretinol (ALK-001), is currently being evaluated in clinical trials for the treatment of Stargardt disease and for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alkeus Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Seemi
Likely contact at this company
••••••••@••••••••

See Seemi's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Alkeus Pharmaceuticals's next move

Learn about Strategic plan

Alkeus Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.